Best-in-class therapeutics
Leveraging proven mechanisms of action & next-generation novel compounds

PurMinds' science team is developing next generation therapeutics for neurological disorders by harnessing scientific rigor, leveraging strong strategic partnerships and developing an innovative approach to drug development with a focus on inducing neuroplasticity, reducing neuro-inflammation and promoting neuro-rejuvenation.  

 

We believe neuroplastogens and psychoplastogens offer new beacon of hope for Central Nervous System diseases, riding on exciting clinical data and recognition by regulatory bodies and the scientific community for psychiatric and neurological conditions where traditional therapies have largely failed. 

 

​